Medicines regulator Swissmedic has approved the booster of the single-dose vaccine from Johnson & Johnson.
“The second dose of the vaccine can be administered, at the earliest, two months after the first dose,” wrote Swissmedic in a statement on Monday.
Swissmedic has also approved the use of Janssen as a booster for mRNA vaccines. It can be administered six months after the second dose of an mRNA vaccine.
“This is the first time in Switzerland that an applicant has submitted clinical data on a mixed vaccination,” wrote Swissmedic.
The Janssen viral vector model vaccine was first approved in March. In September the Swiss government signed a contract to purchase 150,000 doses. The vaccine is based on a human cold virus that contains the blueprint for the “spike” protein of the novel coronavirus.
The other two vaccines approved in Switzerland – Moderna and by Pfizer/BioNTech – use mRNA technology, a process that injects a fragment of the coronavirus blueprint into human cells to prompt the body to produce a defensive response.
Moderna boost
The Swiss government has exercised its option to purchase an additional seven million doses of Moderna’s booster vaccine for delivery in the second half of 2022, the company said on Monday. These vaccine, approved as booster in November, would be in addition to the first seven million doses ordered by the government for 2022. In total, this brings Switzerland’s order to 27.5 million doses of the mRNA vaccine.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Switzerland wants to examine cooperation with the EU in the defence sector
This content was published on
The Federal Council wants to examine a security and defence partnership with the EU. Exploratory talks are to begin as soon as possible. Among other things, the partnership would be used for defence procurement.
Swiss trial shows organic farming is 85% as productive as conventional agriculture
This content was published on
This is shown by the results of a globally unique open-air trial that has been running for 47 years in Therwil in the canton of Basel-Landschaft.
Nestlé fined by Swiss canton for illegally filtered water
This content was published on
Nestlé has been fined CHF 500,000 in the canton of Vaud for the unauthorised use of activated carbon filters in the production of mineral water. The filters were used to produce Henniez water from 2008 to 2022.
Swiss government proposes restrictions on Ukrainian refugees
This content was published on
Only those whose life and limb are at risk in Ukraine and who flee to Switzerland are to be granted S status in future. The remaining Ukrainian refugees should apply for asylum. This is what the Federal Council is proposing.
This content was published on
The Fribourg parliament approved a sum of CHF6.4 million to renovate the ramparts, the walkway and the towers, as well as to replace the exterior lighting.
Swiss rental housing listings increase for the first time in three years
This content was published on
For the first time in three years, the number of advertisements for rental accommodation is on the rise, but this does not dampen demand, quite the contrary. In Ticino, the average duration of an advertisement published on the main portals is 30 days.
Switzerland doing relatively well when it comes to child vaccination rates
This content was published on
Progress in child immunisation has stalled. For decades, the number of children vaccinated against measles, polio and other diseases has risen. But since 2010, vaccination rates have stagnated in many countries, according to a study.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss regulator approves Pfizer/BioNTech booster for 16 and up
This content was published on
Swissmedic has approved the extension of Covid-19 boosters to all people 16 years of age and over for the Pfizer/BioNTech vaccine.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.